Houlihan Lokey Advises Numan

Houlihan Lokey is pleased to announce that Numan, a U.K. leader in preventative digital healthcare, has raised $60 million in fresh funding, led by Big Pi Ventures.

Numan’s mission is to enable healthier, happier, and longer lives by transforming the way people experience and think about healthcare. Using proprietary technology and data, Numan is building a comprehensive, preventative health platform that bridges the gap between prevention and cure, uniting diagnostics, medication, expert care, and behavioural change into one seamless patient journey. The new funding will fuel Numan’s growth, including its preventative health mission and expansion into international markets. The fundraise also includes access to $27 million in growth capital from HSBC Innovation Banking, which supports the U.K.’s leading health technology innovators and investors.

Big Pi Ventures is a multi-stage equity investor in technology businesses. It partners with teams developing exceptional technologies or differentiated business models, actively supporting them through their journeys and investing in opportunities that can change lives for the better or transform markets and sectors. Its platform focuses on international companies and markets in both early and growth stages.

Houlihan Lokey served as the exclusive financial advisor to Numan, supporting key aspects of the transaction, leveraging the firm’s strong relationships with European growth equity investors and its best-in-class structuring expertise.

RELATED: Healthcare, Global Healthcare Technology, Capital Solutions